FDA — authorised 18 March 1957
- Marketing authorisation holder: ASPEN GLOBAL INC
- Status: approved
🇺🇸 Leukeran in United States
FDA authorised Leukeran on 18 March 1957
Marketing authorisations
FDA — authorised 18 March 1957
- Application: NDA010669
- Marketing authorisation holder: WAYLIS THERAP
- Local brand name: LEUKERAN
- Indication: TABLET — ORAL
- Status: approved
Leukeran in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Leukeran approved in United States?
Yes. FDA authorised it on 18 March 1957; FDA authorised it on 18 March 1957.
Who is the marketing authorisation holder for Leukeran in United States?
ASPEN GLOBAL INC holds the US marketing authorisation.